Center for Innovation welcomes Larry D. Rigby to the entrepreneur forum March 8
The Center for Innovation and the Dakota Venture Group welcomes entrepreneur and investor Larry D. Rigby, founder and CEO of Larada Sciences, to the next entrepreneur forum at 5 p.m. Tuesday, March 8, in the Ina Mae Rude Entrepreneur Center Idea Lab. Free visitor parking is available.
Larry D. Rigby is founder, chairman and CEO of Larada Sciences, a University of Utah spinoff. He was co-founder and chief executive officer of ZARS Pharma from 1996 to January 2006. He is currently vice chairman of ZARS. Rigby started his medical career with Sorenson Research Company in August 1975, where he was vice president of sales and marketing. From August 1982 to August 1985, he was president of Martin U.S.A., a subsidiary of the German company Gebrűder Martin.
From August 1985 to June 1995, Rigby was chairman and founder of Alton Dean Medical, which was acquired by Mallinckrodt Medical in June 1995. In August 1986, he founded and became chief executive officer of CardioPulmonics, which went public in 1992 and later merged with Innerdyne and then again with Tyco. Rigby was recently president of MicroJect, a company he founded in 1993, which was acquired in 1998 by Sorenson Development. He is a co-founder and former director of Kalypto Medical, co-founder and chairman of Aplion Medical, and current chairman of VisualShare, Inc. He serves as chairman of Exeven Therapeutics, a University of Utah spinout that he cofounded. He is co-founder of The Salt Lake Life Science Angels.
Rigby has a B.A. from Idaho State University, an M.A. from the University of Kansas and further graduate work at The Johns Hopkins University. Idaho State University honored him in 2006 with its Distinguished Alumni Award.
The Entrepreneur Forum is a periodical gathering of entrepreneurs and business people who share experiences, strategies and success stories. The event is free and open to the public.
-- Eric Veidel, Center for Innovation, 777-3132, firstname.lastname@example.org.